Skip to main content

Want a detailed portfolio tracker?

ZyVersa Therapeutics (ZVSA) P/E (2023 - 2026)

ZyVersa Therapeutics (ZVSA) P/E from Jan 3, 2023 to Jul 21, 2026. The TTM ZyVersa Therapeutics (ZVSA) P/E is -0.04. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of ZyVersa Therapeutics (ZVSA)

YearP/EChange
2026-0.04+4.67%
2025-0.03-49.10%
2024-0.07-73.00%
2023-0.25N/A

Comparison ZyVersa Therapeutics (ZVSA) P/E with competitors

ZyVersa Therapeutics (ZVSA) P/E is -0.04.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-104.70%
NBYStablecoin Development Corp0.00-111.88%
ENLVEnlivex Ltd0.07-306.70%
FGENFibroGen Inc0.24-763.29%
CHRSCoherus Biosciences Inc0.85-2444.70%
FBIOFortress Biotech Inc0.95-2722.41%
ORMPOramed Pharmaceuticals Inc1.50-4253.31%
AGENAgenus Inc3.01-8416.29%
INVAInnoviva Inc3.15-8815.31%
VXRTVaxart Inc3.55-9908.77%
CRMDCorMedix Inc3.63-10126.24%
CVACCureVac N.V.4.45-12384.45%
GLPGGalapagos NV4.86-13526.26%
SRPTSarepta Therapeutics Inc4.88-13590.37%
ABEOAbeona Therapeutics Inc5.39-14986.97%
ABUSArbutus Biopharma Corp5.60-15562.02%
SPROSpero Therapeutics Inc6.23-17310.66%
CGENCompugen Ltd6.31-17546.93%
RIGLRigel Pharmaceuticals6.87-19089.15%
SLXNSilexion Therapeutics Corp7.30-20260.81%
OMEROmeros Corporation9.26-25684.15%
AUPHAurinia Pharmaceuticals Inc9.58-26585.56%
PLXProtalix BioTherapeutics Inc10.89-30194.48%
ACADAcadia Pharmaceuticals Inc11.73-32508.79%
TBPHTheravance Biopharma Inc12.26-33983.31%
ADMAAdma Biologics Inc12.42-34414.39%
HRMYHarmony Biosciences Holdings Inc13.82-38288.60%
SABSSAB Biotherapeutics Inc14.14-39161.81%
NAGENiagen Bioscience Inc14.82-41046.14%
INCYIncyte Corp15.82-43821.64%
REGNRegeneron Pharmaceuticals Inc15.86-43915.87%
PBYIPuma Biotechnology Inc17.32-47947.59%
CPRXCatalyst Pharmaceuticals Inc17.44-48289.14%
EXELExelixis Inc17.54-48561.89%
TGTXTG Therapeutics Inc18.97-52507.94%
MDXGMimedx Group Inc20.55-56891.71%
XOMAXOMA Royalty Corp22.87-63310.13%
ARGXArgen X SE24.30-67243.20%
CTMXCytomX Therapeutics Inc24.82-68688.71%
XOMAOXOMA Royalty Corp25.34-70135.87%
HALOHalozyme Therapeutics Inc25.62-70906.57%
XOMAPXOMA Royalty Corp25.67-71034.79%
VRTXVertex Pharmaceuticals Inc27.99-77458.46%
RPRXRoyalty Pharma plc - Class A28.69-79372.90%
SLNOSoleno Therapeutics Inc29.02-80278.73%
ASNDAscendis Pharma A/S30.09-83236.06%
LGNDLigand Pharmaceuticals Inc - Class B37.91-104863.10%
APLSApellis Pharmaceuticals Inc39.02-107928.21%
BMRNBiomarin Pharmaceutical Inc42.21-116744.93%
KRYSKrystal Biotech Inc45.34-125398.62%
ONCBeiGene Ltd69.54-192262.73%
PHARPharming Group N.V.75.03-207419.95%
TECHBio-Techne Corp101.96-281844.02%
VCELVericel Corp109.92-303848.25%
ALNYAlnylam Pharmaceuticals Inc117.96-326075.77%
GMABGenmab140.29-387768.83%
TLXTelix Pharmaceuticals Ltd162.15-448180.80%
CORTCorcept Therapeutics Inc212.86-588294.27%